CN103435689B - Molecular chaperone TSPcpn47 and polynucleotide encoding same - Google Patents
Molecular chaperone TSPcpn47 and polynucleotide encoding same Download PDFInfo
- Publication number
- CN103435689B CN103435689B CN201310364132.8A CN201310364132A CN103435689B CN 103435689 B CN103435689 B CN 103435689B CN 201310364132 A CN201310364132 A CN 201310364132A CN 103435689 B CN103435689 B CN 103435689B
- Authority
- CN
- China
- Prior art keywords
- tspcpn47
- molecular chaperone
- protein
- solution
- add
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 108010006519 Molecular Chaperones Proteins 0.000 title claims abstract description 46
- 102000005431 Molecular Chaperones Human genes 0.000 title claims abstract description 44
- 239000002157 polynucleotide Substances 0.000 title claims abstract description 6
- 102000040430 polynucleotide Human genes 0.000 title claims abstract description 6
- 108091033319 polynucleotide Proteins 0.000 title claims abstract description 6
- 239000002773 nucleotide Substances 0.000 claims abstract description 4
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 abstract description 47
- 102000004169 proteins and genes Human genes 0.000 abstract description 38
- 101100208245 Danio rerio thbs4b gene Proteins 0.000 abstract description 7
- 101150053966 THBS4 gene Proteins 0.000 abstract description 7
- 102100029219 Thrombospondin-4 Human genes 0.000 abstract description 7
- 238000004925 denaturation Methods 0.000 abstract description 4
- 230000036425 denaturation Effects 0.000 abstract description 4
- 241000589596 Thermus Species 0.000 abstract description 3
- 241001515965 unidentified phage Species 0.000 abstract description 3
- 230000004845 protein aggregation Effects 0.000 abstract description 2
- 230000014616 translation Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 30
- 230000000694 effects Effects 0.000 description 20
- 239000013612 plasmid Substances 0.000 description 20
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 19
- 238000006243 chemical reaction Methods 0.000 description 14
- 239000005090 green fluorescent protein Substances 0.000 description 14
- 239000006228 supernatant Substances 0.000 description 14
- 241000894006 Bacteria Species 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 12
- 238000001962 electrophoresis Methods 0.000 description 12
- 230000001580 bacterial effect Effects 0.000 description 11
- 239000012634 fragment Substances 0.000 description 11
- 230000014509 gene expression Effects 0.000 description 11
- 238000000034 method Methods 0.000 description 10
- 238000001179 sorption measurement Methods 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 9
- 239000000872 buffer Substances 0.000 description 9
- 238000001514 detection method Methods 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 230000009182 swimming Effects 0.000 description 9
- 108091006112 ATPases Proteins 0.000 description 8
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 7
- 229940098773 bovine serum albumin Drugs 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 239000002244 precipitate Substances 0.000 description 7
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 6
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 6
- 239000003480 eluent Substances 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 6
- 108010047956 Nucleosomes Proteins 0.000 description 5
- 229910019142 PO4 Inorganic materials 0.000 description 5
- 229960000723 ampicillin Drugs 0.000 description 5
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 5
- 230000003321 amplification Effects 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 238000001976 enzyme digestion Methods 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 210000001623 nucleosome Anatomy 0.000 description 5
- 239000010452 phosphate Substances 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 238000012546 transfer Methods 0.000 description 5
- 239000013598 vector Substances 0.000 description 5
- 102000006382 Ribonucleases Human genes 0.000 description 4
- 108010083644 Ribonucleases Proteins 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 238000005119 centrifugation Methods 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 239000002699 waste material Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 3
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 3
- 108010033040 Histones Proteins 0.000 description 3
- 102000002488 Nucleoplasmin Human genes 0.000 description 3
- 102000004142 Trypsin Human genes 0.000 description 3
- 108090000631 Trypsin Proteins 0.000 description 3
- 239000011543 agarose gel Substances 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- 108060005597 nucleoplasmin Proteins 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000011550 stock solution Substances 0.000 description 3
- 239000012588 trypsin Substances 0.000 description 3
- 102000002812 Heat-Shock Proteins Human genes 0.000 description 2
- 108010004889 Heat-Shock Proteins Proteins 0.000 description 2
- 102000006947 Histones Human genes 0.000 description 2
- 241000997743 Thermus phage TSP4 Species 0.000 description 2
- YVNQAIFQFWTPLQ-UHFFFAOYSA-O [4-[[4-(4-ethoxyanilino)phenyl]-[4-[ethyl-[(3-sulfophenyl)methyl]amino]-2-methylphenyl]methylidene]-3-methylcyclohexa-2,5-dien-1-ylidene]-ethyl-[(3-sulfophenyl)methyl]azanium Chemical compound C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C(=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S(O)(=O)=O)C)C=2C(=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S(O)(=O)=O)C)C=C1 YVNQAIFQFWTPLQ-UHFFFAOYSA-O 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 150000002460 imidazoles Chemical class 0.000 description 2
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 239000012474 protein marker Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 238000004153 renaturation Methods 0.000 description 2
- 230000035939 shock Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000012192 staining solution Substances 0.000 description 2
- 238000001890 transfection Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- CVOFKRWYWCSDMA-UHFFFAOYSA-N 2-chloro-n-(2,6-diethylphenyl)-n-(methoxymethyl)acetamide;2,6-dinitro-n,n-dipropyl-4-(trifluoromethyl)aniline Chemical compound CCC1=CC=CC(CC)=C1N(COC)C(=O)CCl.CCCN(CCC)C1=C([N+]([O-])=O)C=C(C(F)(F)F)C=C1[N+]([O-])=O CVOFKRWYWCSDMA-UHFFFAOYSA-N 0.000 description 1
- KQROHCSYOGBQGJ-UHFFFAOYSA-N 5-Hydroxytryptophol Chemical compound C1=C(O)C=C2C(CCO)=CNC2=C1 KQROHCSYOGBQGJ-UHFFFAOYSA-N 0.000 description 1
- YAXNATKKPOWVCP-ZLUOBGJFSA-N Ala-Asn-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O YAXNATKKPOWVCP-ZLUOBGJFSA-N 0.000 description 1
- CVGNCMIULZNYES-WHFBIAKZSA-N Ala-Asn-Gly Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O CVGNCMIULZNYES-WHFBIAKZSA-N 0.000 description 1
- KIUYPHAMDKDICO-WHFBIAKZSA-N Ala-Asp-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O KIUYPHAMDKDICO-WHFBIAKZSA-N 0.000 description 1
- OMMDTNGURYRDAC-NRPADANISA-N Ala-Glu-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O OMMDTNGURYRDAC-NRPADANISA-N 0.000 description 1
- MEFILNJXAVSUTO-JXUBOQSCSA-N Ala-Leu-Thr Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MEFILNJXAVSUTO-JXUBOQSCSA-N 0.000 description 1
- RMAWDDRDTRSZIR-ZLUOBGJFSA-N Ala-Ser-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O RMAWDDRDTRSZIR-ZLUOBGJFSA-N 0.000 description 1
- LLZXKVAAEWBUPB-KKUMJFAQSA-N Arg-Gln-Phe Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O LLZXKVAAEWBUPB-KKUMJFAQSA-N 0.000 description 1
- NVCIXQYNWYTLDO-IHRRRGAJSA-N Arg-His-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCCN=C(N)N)N NVCIXQYNWYTLDO-IHRRRGAJSA-N 0.000 description 1
- SUMJNGAMIQSNGX-TUAOUCFPSA-N Arg-Val-Pro Chemical compound CC(C)[C@H](NC(=O)[C@@H](N)CCCNC(N)=N)C(=O)N1CCC[C@@H]1C(O)=O SUMJNGAMIQSNGX-TUAOUCFPSA-N 0.000 description 1
- FHETWELNCBMRMG-HJGDQZAQSA-N Asn-Leu-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O FHETWELNCBMRMG-HJGDQZAQSA-N 0.000 description 1
- WLVLIYYBPPONRJ-GCJQMDKQSA-N Asn-Thr-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O WLVLIYYBPPONRJ-GCJQMDKQSA-N 0.000 description 1
- OERMIMJQPQUIPK-FXQIFTODSA-N Asp-Arg-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O OERMIMJQPQUIPK-FXQIFTODSA-N 0.000 description 1
- 238000009010 Bradford assay Methods 0.000 description 1
- 108050001186 Chaperonin Cpn60 Proteins 0.000 description 1
- 102000052603 Chaperonins Human genes 0.000 description 1
- 102100026992 Dermcidin Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- WQWMZOIPXWSZNE-WDSKDSINSA-N Gln-Asp-Gly Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O WQWMZOIPXWSZNE-WDSKDSINSA-N 0.000 description 1
- KUBFPYIMAGXGBT-ACZMJKKPSA-N Gln-Ser-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O KUBFPYIMAGXGBT-ACZMJKKPSA-N 0.000 description 1
- UEILCTONAMOGBR-RWRJDSDZSA-N Gln-Thr-Ile Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O UEILCTONAMOGBR-RWRJDSDZSA-N 0.000 description 1
- PYTZFYUXZZHOAD-WHFBIAKZSA-N Gly-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)CN PYTZFYUXZZHOAD-WHFBIAKZSA-N 0.000 description 1
- YFGONBOFGGWKKY-VHSXEESVSA-N Gly-His-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CN=CN2)NC(=O)CN)C(=O)O YFGONBOFGGWKKY-VHSXEESVSA-N 0.000 description 1
- SYOJVRNQCXYEOV-XVKPBYJWSA-N Gly-Val-Glu Chemical compound [H]NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SYOJVRNQCXYEOV-XVKPBYJWSA-N 0.000 description 1
- 101710203592 Heat shock protein 100 Proteins 0.000 description 1
- 108091082017 Heat shock protein 70 family Proteins 0.000 description 1
- 102000042775 Heat shock protein 70 family Human genes 0.000 description 1
- 102100032510 Heat shock protein HSP 90-beta Human genes 0.000 description 1
- STGQSBKUYSPPIG-CIUDSAMLSA-N His-Ser-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CN=CN1 STGQSBKUYSPPIG-CIUDSAMLSA-N 0.000 description 1
- 101000911659 Homo sapiens Dermcidin Proteins 0.000 description 1
- 101001016856 Homo sapiens Heat shock protein HSP 90-beta Proteins 0.000 description 1
- YKRIXHPEIZUDDY-GMOBBJLQSA-N Ile-Asn-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N YKRIXHPEIZUDDY-GMOBBJLQSA-N 0.000 description 1
- SAEWJTCJQVZQNZ-IUKAMOBKSA-N Ile-Thr-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N SAEWJTCJQVZQNZ-IUKAMOBKSA-N 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- TYYLDKGBCJGJGW-UHFFFAOYSA-N L-tryptophan-L-tyrosine Natural products C=1NC2=CC=CC=C2C=1CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 TYYLDKGBCJGJGW-UHFFFAOYSA-N 0.000 description 1
- 101000839464 Leishmania braziliensis Heat shock 70 kDa protein Proteins 0.000 description 1
- 101000988090 Leishmania donovani Heat shock protein 83 Proteins 0.000 description 1
- MJOZZTKJZQFKDK-GUBZILKMSA-N Leu-Ala-Gln Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(N)=O MJOZZTKJZQFKDK-GUBZILKMSA-N 0.000 description 1
- ILJREDZFPHTUIE-GUBZILKMSA-N Leu-Asp-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O ILJREDZFPHTUIE-GUBZILKMSA-N 0.000 description 1
- VQPPIMUZCZCOIL-GUBZILKMSA-N Leu-Gln-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O VQPPIMUZCZCOIL-GUBZILKMSA-N 0.000 description 1
- ZTLGVASZOIKNIX-DCAQKATOSA-N Leu-Gln-Glu Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N ZTLGVASZOIKNIX-DCAQKATOSA-N 0.000 description 1
- HVJVUYQWFYMGJS-GVXVVHGQSA-N Leu-Glu-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O HVJVUYQWFYMGJS-GVXVVHGQSA-N 0.000 description 1
- DBSLVQBXKVKDKJ-BJDJZHNGSA-N Leu-Ile-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O DBSLVQBXKVKDKJ-BJDJZHNGSA-N 0.000 description 1
- RTIRBWJPYJYTLO-MELADBBJSA-N Leu-Lys-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@@H]1C(=O)O)N RTIRBWJPYJYTLO-MELADBBJSA-N 0.000 description 1
- ZJZNLRVCZWUONM-JXUBOQSCSA-N Leu-Thr-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O ZJZNLRVCZWUONM-JXUBOQSCSA-N 0.000 description 1
- RIHIGSWBLHSGLV-CQDKDKBSSA-N Leu-Tyr-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(O)=O RIHIGSWBLHSGLV-CQDKDKBSSA-N 0.000 description 1
- NTSPQIONFJUMJV-AVGNSLFASA-N Lys-Arg-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O NTSPQIONFJUMJV-AVGNSLFASA-N 0.000 description 1
- GCMWRRQAKQXDED-IUCAKERBSA-N Lys-Glu-Gly Chemical compound [NH3+]CCCC[C@H]([NH3+])C(=O)N[C@@H](CCC([O-])=O)C(=O)NCC([O-])=O GCMWRRQAKQXDED-IUCAKERBSA-N 0.000 description 1
- CTVJSFRHUOSCQQ-DCAQKATOSA-N Met-Arg-Glu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O CTVJSFRHUOSCQQ-DCAQKATOSA-N 0.000 description 1
- 108060004795 Methyltransferase Proteins 0.000 description 1
- BQVUABVGYYSDCJ-UHFFFAOYSA-N Nalpha-L-Leucyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)CC(C)C)C(O)=O)=CNC2=C1 BQVUABVGYYSDCJ-UHFFFAOYSA-N 0.000 description 1
- 108010061100 Nucleoproteins Proteins 0.000 description 1
- 102000011931 Nucleoproteins Human genes 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- MSSXKZBDKZAHCX-UNQGMJICSA-N Phe-Thr-Val Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O MSSXKZBDKZAHCX-UNQGMJICSA-N 0.000 description 1
- AJLVKXCNXIJHDV-CIUDSAMLSA-N Pro-Ala-Gln Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(O)=O AJLVKXCNXIJHDV-CIUDSAMLSA-N 0.000 description 1
- YFNOUBWUIIJQHF-LPEHRKFASA-N Pro-Asp-Pro Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CC(=O)O)C(=O)N2CCC[C@@H]2C(=O)O YFNOUBWUIIJQHF-LPEHRKFASA-N 0.000 description 1
- WTUJZHKANPDPIN-CIUDSAMLSA-N Ser-Ala-Lys Chemical compound C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)N WTUJZHKANPDPIN-CIUDSAMLSA-N 0.000 description 1
- XUDRHBPSPAPDJP-SRVKXCTJSA-N Ser-Lys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO XUDRHBPSPAPDJP-SRVKXCTJSA-N 0.000 description 1
- QUGRFWPMPVIAPW-IHRRRGAJSA-N Ser-Pro-Phe Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 QUGRFWPMPVIAPW-IHRRRGAJSA-N 0.000 description 1
- HSWXBJCBYSWBPT-GUBZILKMSA-N Ser-Val-Val Chemical compound CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C(C)C)C(O)=O HSWXBJCBYSWBPT-GUBZILKMSA-N 0.000 description 1
- BSNZTJXVDOINSR-JXUBOQSCSA-N Thr-Ala-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O BSNZTJXVDOINSR-JXUBOQSCSA-N 0.000 description 1
- PWONLXBUSVIZPH-RHYQMDGZSA-N Thr-Val-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N)O PWONLXBUSVIZPH-RHYQMDGZSA-N 0.000 description 1
- WNZRNOGHEONFMS-PXDAIIFMSA-N Trp-Ile-Tyr Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O WNZRNOGHEONFMS-PXDAIIFMSA-N 0.000 description 1
- JHDZONWZTCKTJR-KJEVXHAQSA-N Tyr-Thr-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 JHDZONWZTCKTJR-KJEVXHAQSA-N 0.000 description 1
- RVGVIWNHABGIFH-IHRRRGAJSA-N Tyr-Val-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O RVGVIWNHABGIFH-IHRRRGAJSA-N 0.000 description 1
- 101710100170 Unknown protein Proteins 0.000 description 1
- TZVUSFMQWPWHON-NHCYSSNCSA-N Val-Asp-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C(C)C)N TZVUSFMQWPWHON-NHCYSSNCSA-N 0.000 description 1
- ROLGIBMFNMZANA-GVXVVHGQSA-N Val-Glu-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)N ROLGIBMFNMZANA-GVXVVHGQSA-N 0.000 description 1
- FTKXYXACXYOHND-XUXIUFHCSA-N Val-Ile-Leu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(O)=O FTKXYXACXYOHND-XUXIUFHCSA-N 0.000 description 1
- VNGKMNPAENRGDC-JYJNAYRXSA-N Val-Phe-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)CC1=CC=CC=C1 VNGKMNPAENRGDC-JYJNAYRXSA-N 0.000 description 1
- YTNGABPUXFEOGU-SRVKXCTJSA-N Val-Pro-Arg Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O YTNGABPUXFEOGU-SRVKXCTJSA-N 0.000 description 1
- 241000269368 Xenopus laevis Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 108010047495 alanylglycine Proteins 0.000 description 1
- 108010070783 alanyltyrosine Proteins 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 108010001271 arginyl-glutamyl-arginine Proteins 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 239000006143 cell culture medium Substances 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001506 fluorescence spectroscopy Methods 0.000 description 1
- 239000006481 glucose medium Substances 0.000 description 1
- 108010050848 glycylleucine Proteins 0.000 description 1
- 108010015792 glycyllysine Proteins 0.000 description 1
- 108010037850 glycylvaline Proteins 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 108091070631 heat shock protein 90 family Proteins 0.000 description 1
- 102000040622 heat shock protein 90 family Human genes 0.000 description 1
- 108010092114 histidylphenylalanine Proteins 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 108010090333 leucyl-lysyl-proline Proteins 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 230000002934 lysing effect Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229940085991 phosphate ion Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000001742 protein purification Methods 0.000 description 1
- 230000030788 protein refolding Effects 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000003259 recombinant expression Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 108010048397 seryl-lysyl-leucine Proteins 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000012096 transfection reagent Substances 0.000 description 1
- 108010044292 tryptophyltyrosine Proteins 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明公开了一种分子伴侣TSPcpn47和编码该分子伴侣的多核苷酸,该分子伴侣TSPcpn47来源于高温栖热菌的噬菌体TSP4,能起到稳定蛋白质结构的作用并防止蛋白质凝聚、变性,提高蛋白质的稳定性,其核苷酸序列可用于构建生产此分子伴侣的基因工程菌株。The invention discloses a molecular chaperone TSPcpn47 and a polynucleotide encoding the molecular chaperone. The molecular chaperone TSPcpn47 is derived from the bacteriophage TSP4 of Thermus thermus, which can stabilize the protein structure and prevent protein aggregation and denaturation, and improve protein production. stability, and its nucleotide sequence can be used to construct genetically engineered strains producing this molecular chaperone.
Description
技术领域 technical field
本发明涉及一种分子伴侣TSPcpn47和编码此分子伴侣的多核苷酸,分子伴侣在生物体内起着稳定新生蛋白、辅助其他蛋白质正确折叠,提高蛋白质的稳定性,属于生物技术领域。 The present invention relates to a molecular chaperone TSPcpn47 and a polynucleotide encoding the molecular chaperone. The molecular chaperone stabilizes nascent proteins in organisms, assists other proteins in correct folding, and improves protein stability, and belongs to the field of biotechnology. the
背景技术 Background technique
分子伴侣是一类在进化上非常保守的蛋白质家族,它能非特异性结合不同结构、大小和功能的蛋白质并催化介导这些蛋白质形成特定的构象,在生物体内起着稳定新生蛋白、辅助其他蛋白质正确折叠、组装、转运甚至降解的作用,在胁迫条件下,分子伴侣起到稳定蛋白质结构的作用并防止蛋白质凝聚、变性,还具有修复变性蛋白的功能,对蛋白质功能的发挥具有重要意义。 Molecular chaperones are a family of proteins that are very conserved in evolution. They can non-specifically bind proteins of different structures, sizes and functions and catalyze the formation of specific conformations of these proteins. They play a role in stabilizing new proteins and assisting other proteins in organisms. Correct folding, assembly, transport and even degradation. Under stress conditions, molecular chaperones can stabilize protein structure and prevent protein aggregation and denaturation. They also have the function of repairing denatured proteins, which is of great significance to the function of proteins. the
第一个分子伴侣----核质蛋白(nucleoplasmin)是Laskey等人于1978年在非洲爪蟾卵的浸出液中发现的,他们通过研究组蛋白与DNA结合形成核小体的过程中,必须依靠一种酸性核蛋白(nucleoplasmin) 的参与才能完成它们的装配。体外试验也表明,只有将组蛋白与过量的酸性核蛋白混合,才能令其与后加入的DNA组装最终形成核小体结构,但形成的核小体中并没有酸性核蛋白。当仅有DNA与组蛋白存在时,并不能自我组装成核小体结构,而是形成沉淀。 The first molecular chaperone - nucleoplasmin (nucleoplasmin) was discovered by Laskey et al. in the leaching solution of Xenopus laevis eggs in 1978. They must study the process of histone binding to DNA to form nucleosomes. Their assembly depends on the participation of an acidic nucleoplasmin. In vitro experiments also showed that only by mixing histones with excess acidic nucleoproteins can they be assembled with the added DNA to finally form a nucleosome structure, but there is no acidic nucleosomes in the formed nucleosomes. When only DNA and histones are present, they cannot self-assemble into nucleosome structures, but form precipitates. the
迄 今 为 止 发 现 的 大 多 数 的 分 子 伴 侣 都 属 于 热 休 克 蛋 白 (heat shock protein,HSP)的范畴,大 致 可 主 要 分 为 伴 侣 素 家 族 (chaperonin,Cpn )、热 休 克 蛋 白 7 0 家 族 (HSP 70 family)、热 休 克 蛋 白 9 0 家 族 (HSP 90 family)以及热休克蛋白100家族等保守的蛋白家族,目前还没有来源于栖热菌噬菌体的分子伴侣的报道,分子伴侣因其可以提高蛋白质(酶)的稳定性而使其在工业上具有应用价值。 Most of the molecular chaperones discovered so far belong to the category of heat shock protein (HSP), which can be roughly divided into chaperonin (Cpn) family , heat shock protein 70 family (HSP 70 family), heat shock protein 90 family (HSP 90 family) and heat shock protein 100 family, and other conserved protein families, have not yet been derived from Thermus Molecular chaperones of bacteriophages have been reported. Molecular chaperones have industrial application value because they can improve the stability of proteins (enzymes). the
发明内容 Contents of the invention
本发明旨在提供一种分子伴侣TSPcpn47,该分子伴侣TSPcpn47来源于高温栖热菌的噬菌体TSP4,其氨基酸序列如SEQ ID NO:1所示。 The present invention aims to provide a molecular chaperone TSPcpn47, the molecular chaperone TSPcpn47 is derived from the bacteriophage TSP4 of Thermus thermophila, and its amino acid sequence is shown in SEQ ID NO:1. the
本发明的另一个目的是提供一种编码分子伴侣TSPcpn47的多核苷酸,其核苷酸序列如SEQ ID NO:2所示。 Another object of the present invention is to provide a polynucleotide encoding molecular chaperone TSPcpn47, the nucleotide sequence of which is shown in SEQ ID NO:2. the
本发明的有益效果: Beneficial effects of the present invention:
本发明获得的栖热菌噬菌体TSP4的分子伴侣TSPcpn47,能够单独的行使分子伴侣功能,即帮助变性的蛋白复性,并且防止其它蛋白在高温、酸性等条件下变性,可利用于在高温等环境下协助功能蛋白保持其活性,减少蛋白变性,对保护功能蛋白的生理活性具有重要作用,其核苷酸序列可以用于构建能催化形成以上产物的基因工程菌株。 The molecular chaperone TSPcpn47 of the Thermus phage TSP4 obtained in the present invention can independently perform the function of a molecular chaperone, that is, to help denatured protein refolding, and prevent other proteins from denaturing under high temperature, acidic conditions, etc., and can be used in high temperature and other environments It assists the functional protein to maintain its activity, reduces protein denaturation, and plays an important role in protecting the physiological activity of the functional protein. Its nucleotide sequence can be used to construct genetically engineered strains that can catalyze the formation of the above products.
附图说明 Description of drawings
图1是本发明分子伴侣TSPcpn47基因的克隆片段电泳示意图; Fig. 1 is the cloning fragment electrophoresis schematic diagram of molecular chaperone TSPcpn47 gene of the present invention;
图2是本发明分子伴侣TSPcpn47基因保守结构域分析示意图; Fig. 2 is a schematic diagram of analysis of the conserved domain of the molecular chaperone TSPcpn47 gene of the present invention;
图3是本发明分子伴侣TSPcpn47基因、pET-28a(+)的酶切示意图,其中泳道1为分子伴侣TSPcpn47基因的酶切胶回收产物,泳道2为pET-28a(+),泳道3为Marker; Figure 3 is a schematic diagram of enzyme digestion of molecular chaperone TSPcpn47 gene and pET-28a(+) of the present invention, wherein swimming lane 1 is the product recovered from enzyme digestion gel of molecular chaperone TSPcpn47 gene, swimming lane 2 is pET-28a(+), and swimming lane 3 is Marker ;
图4是本发明分子伴侣TSPcpn47基因表达蛋白的SDS-PAGE分析检测电泳图,其大小为为29000道尔顿,其中泳道1为Protein Marker;泳道2为Ro-pET28a破碎后的上清;泳道3Ro-pET28a-TSPcpn47破碎后的上清;泳道4为Ro-pET28a破碎后的沉淀;泳道5为Ro-pET28a-TSPcpn47破碎后的沉淀。 Fig. 4 is the SDS-PAGE analysis detection electrophoresis figure of molecular chaperone TSPcpn47 gene expression protein of the present invention, and its size is 29000 Daltons, wherein swimming lane 1 is Protein Marker; Swimming lane 2 is the supernatant after Ro-pET28a is broken; -pET28a- TSPcpn47 crushed supernatant; lane 4 is the precipitate of Ro-pET28a crushed; lane 5 is the precipitate of Ro-pET28a- TSPcpn47 crushed.
图5是本发明分子伴侣TSPcpn47纯化SDS-PAGE分析检测电泳图,其中泳道1为Protein Marker;泳道2为pET28a-TSPcpn47/ Rosetta破碎后的上清;泳道3为pET28a-TSPcpn47/ Rosetta破碎后的上清过His-trap柱;泳道4为10mM咪唑洗脱液;泳道5为150mM咪唑洗脱液;泳道6为500mM咪唑洗脱液;泳道7为500mM咪唑洗脱液; Figure 5 is the SDS-PAGE analysis and detection electrophoresis of molecular chaperone TSPcpn47 of the present invention, wherein lane 1 is Protein Marker; lane 2 is the supernatant after fragmentation of pET28a- TSPcpn47 /Rosetta; lane 3 is the supernatant after fragmentation of pET28a- TSPcpn47 /Rosetta Clear His-trap column; Swimming lane 4 is 10mM imidazole eluent; Swimming lane 5 is 150mM imidazole eluent; Swimming lane 6 is 500mM imidazole eluent; Swimming lane 7 is 500mM imidazole eluent;
图6是本发明蛋白含量标准曲线示意图; Fig. 6 is a schematic diagram of the protein content standard curve of the present invention;
图7是本发明磷酸盐浓度标准曲线示意图; Fig. 7 is a schematic diagram of the phosphate concentration standard curve of the present invention;
图8是本发明温度对分子伴侣TSPcpn47活性的影响; Fig. 8 is the influence of the temperature of the present invention on the activity of molecular chaperone TSPcpn47;
图9是本发明分子伴侣TSPcpn47对GFP荧光强度恢复的帮组作用; Fig. 9 is the assisting effect of molecular chaperone TSPcpn47 of the present invention on the recovery of GFP fluorescence intensity;
图10是本发明分子伴侣TSPcpn47对 GFP热稳定性的影响。 Fig. 10 is the effect of molecular chaperone TSPcpn47 of the present invention on the thermal stability of GFP.
具体实施方式 Detailed ways
下面通过实施例对本发明作进一步详细说明,但本发明的内容并不局限于此,本实施例中方法如无特殊说明的均按常规方法操作,所用试剂如无特殊说明的采用常规试剂或按常规方法配置的试剂。 The present invention will be described in further detail below by the examples, but the content of the present invention is not limited thereto, the methods in the present embodiment are all operated according to conventional methods if there is no special instructions, and the reagents used are conventional reagents if there are no special instructions or according to Reagents configured by conventional methods. the
实施例1:分子伴侣TSPcpn47基因的扩增(以栖热菌噬菌体TSP4基因组DNA为模 Embodiment 1: the amplification of molecular chaperone TSPcpn47 gene (using the Thermus phage TSP4 genome DNA as model
板) plate)
(1) TSP4噬菌体分子伴侣TSPcpn47基因扩增所用引物序列如下: (1) The primer sequences used for the amplification of the TSP4 phage molecular chaperone TSPcpn47 gene are as follows:
正向引物:5’- CGGAATTCATGGCACTCTTATCTAAC -3’ Forward primer: 5'- CG GAATTC ATGGCACTCTTATCTAAC -3'
反向引物:5’- ACATCTCGAGCCATGAGGCCACCTCCT -3’ Reverse primer: 5'- ACAT CTCGAG CCATGAGGCCACCTCCT -3'
(2)扩增体系如下: (2) The amplification system is as follows:
表1:扩增反应体系组分 Table 1: Amplification reaction system components
(3)扩增条件如下: (3) The amplification conditions are as follows:
将反应体系混匀,先在95℃预变性4min,然后在95℃变性30 s,60℃退火45 s,72℃延伸90 s,30个循环后,72℃延伸10min,反应完后取产物2μl,在10g/L琼脂糖凝胶中进行电泳分析(见图1)。 Mix the reaction system evenly, pre-denature at 95°C for 4 minutes, then denature at 95°C for 30 s, anneal at 60°C for 45 s, and extend at 72°C for 90 s. After 30 cycles, extend at 72°C for 10 min. After the reaction, take 2 μl of the product , Electrophoresis analysis was carried out in 10g/L agarose gel (see Figure 1).
实施例2:PCR产物的胶回收纯化 Example 2: Gel recovery and purification of PCR products
①在电泳仪中灌制1.0%琼脂糖凝胶; ①Create 1.0% agarose gel in the electrophoresis apparatus;
②将待分离纯化的PCR产物点样电泳,于适当位置停止电泳; ② Apply electrophoresis to the PCR product to be separated and purified, and stop the electrophoresis at an appropriate position;
③在紫外灯下切下含该目的片断的凝胶,转移到1.5ml的Ep管中; ③Cut off the gel containing the target fragment under ultraviolet light, and transfer it to a 1.5ml Ep tube;
④用索莱生物公司胶回收试剂盒进行目的片段的回收,回收方法按说明书进行操作。 ④Recover the target fragment with the Gel Recovery Kit of Soleil Biotechnology Co., Ltd., and the recovery method is operated according to the instructions.
将基因序列提交NCBI数据库Conserved Domain Database蛋白质保守序列分析软件进行分析,dCTP脱氨酶分析结果见图2。 The gene sequence was submitted to the NCBI database Conserved Domain Database protein conservative sequence analysis software for analysis, and the dCTP deaminase analysis results are shown in Figure 2. the
实施例3:重组表达载体的构建Embodiment 3: Construction of recombinant expression vector
(1)带有粘性末端线性载体pET-28a(+)和目的片段的制备 (1) Preparation of the linear vector pET-28a(+) with cohesive ends and the target fragment
为了将目的基因片断连接到表达载体pET-28a(+)上,就需要使目的片断带有粘性末端的片断,即带有酶切位点,同样,为了使目的片断能插入载体中,也需要使载体带有粘性末端,并且使它们的酶切位点相同。 In order to connect the target gene fragment to the expression vector pET-28a(+), it is necessary to make the target fragment have a fragment with sticky ends, that is, a restriction site. Similarly, in order to enable the target fragment to be inserted into the vector, it is also necessary Make vectors with cohesive ends and make their restriction sites the same.
A、pET-28a(+)质粒抽提:用质粒提取试剂盒(索莱宝),操作步骤如下: A. Extraction of pET-28a(+) plasmid: use the plasmid extraction kit (Soleibao), the operation steps are as follows:
菌种活化:无菌接种环蘸取-80℃冻存的含pET-28a(+)质粒的大肠杆菌菌株,三线法接种于氨苄LB平板,37℃培养12-16小时; Strain activation: Dip the Escherichia coli strain containing the pET-28a(+) plasmid frozen at -80°C with a sterile inoculation loop, inoculate it on the ampicillin LB plate with the third-line method, and incubate at 37°C for 12-16 hours;
②增菌并收集菌体:取氨苄青霉素5μl(终浓度100μg/ml)加入5ml LB培养基中;用接种环挑取阳性克隆,接种于Kan+-LB培养基中;然后放入37℃摇床150rmp培养过夜,并将培养的菌液室温12000 rpm离心1 min,使菌体沉淀,弃上清液; ② Enrichment and collection of bacteria: Take 5 μl of ampicillin (final concentration 100 μg/ml) and add it to 5 ml of LB medium; pick positive clones with an inoculation loop and inoculate them in Kan + -LB medium; then shake at 37°C Cultivate overnight on a bed at 150 rpm, centrifuge the cultured bacterial solution at room temperature at 12,000 rpm for 1 min to precipitate the bacterial cells, and discard the supernatant;
③在离心管中加溶液(含RNA酶) 250 μl,振荡至菌体彻底悬浮,转入1.5ml的EP管中; ③ Add the solution to the centrifuge tube (contains RNase) 250 μl, shake until the bacteria are completely suspended, and transfer to a 1.5ml EP tube;
EP管加入溶液 250 μl,轻轻颠倒几次,室温放置3min,使溶液Ⅰ的RNA酶把其中的RNA降解后,加溶液 350 μl,13000 rpm,室温离心10 min; EP tube adding solution 250 μl, gently invert several times, and place at room temperature for 3 minutes to degrade the RNA in solution I by RNase, then add solution 350 μl, centrifuge at 13000 rpm for 10 min at room temperature;
离心后所得的上清液转入DNA吸附柱中,室温离心,12000 rpm,1 min,回收两次,弃废液; The supernatant obtained after centrifugation was transferred to a DNA adsorption column, centrifuged at room temperature, 12000 rpm, 1 min, recovered twice, and the waste liquid was discarded;
吸附柱中加入500 μl漂洗液,12000 rpm室温离心1 min; Add 500 μl of washing solution to the adsorption column, and centrifuge at 12,000 rpm for 1 min at room temperature;
⑦然后加750 μl漂洗液,12000rpm,室温离心1min,弃废液(重复一次);再室温离心一次,13000 rpm,2 min; ⑦ Then add 750 μl rinse solution, centrifuge at room temperature for 1 min at 12,000 rpm, discard the waste solution (repeat once); centrifuge again at room temperature, at 13,000 rpm, for 2 min;
⑧将吸附柱移入新的1.5 ml的离心管中,在吸附膜中央加入70μl 经65℃预热的洗脱液,室温放置2 min,然后,12000 rpm室温离心1 min,弃吸附柱,得到质粒; ⑧ Move the adsorption column into a new 1.5 ml centrifuge tube, add 70 μl of eluent preheated at 65°C to the center of the adsorption membrane, let it stand at room temperature for 2 minutes, then centrifuge at 12000 rpm for 1 minute at room temperature, discard the adsorption column, and obtain the plasmid ;
⑨将所得的质粒取1μl进行电泳检测,并定量。 ⑨ Take 1 μl of the obtained plasmid for electrophoresis detection and quantification.
B、质粒pET-28a(+)、目的片段的酶切鉴定 B. Enzyme digestion identification of plasmid pET-28a(+) and target fragment
表2:反应体系组分 Table 2: Reaction System Components
37℃温育6h,1%琼脂糖凝胶电泳检测双酶切产物,用索莱宝胶回收试剂盒回收双酶切产物(见图3)。 Incubate at 37°C for 6 hours, detect the double-digestion products by 1% agarose gel electrophoresis, and recover the double-digestion products with Solebol Gel Recovery Kit (see Figure 3).
(2)将TSP4噬菌体的分子伴侣TSPcpn47基因片段连接到pET-28a(+)载体上,得到重组质粒 (2) Connect the molecular chaperone TSPcpn47 gene fragment of TSP4 phage to the pET-28a(+) vector to obtain a recombinant plasmid
①连接反应体系如下: ①The connection reaction system is as follows:
表3:反应体系组分 Table 3: Reaction System Components
②条件:16℃,连接过夜。 ②Conditions: 16°C, connect overnight.
(3)重组质粒的转化 (3) Transformation of recombinant plasmids
在100μl感受态细胞DH5a里,加入10μl连接产物,冰浴30min,然后42℃热击2min,再冰浴2min,之后加入400μl LB液体培养基,于37℃摇床,150rpm震荡培养1h,然后涂布含有氨苄青霉素(kan+)的LB固体平板,于37℃倒置培养16h。 In 100 μl of competent cell DH5a, add 10 μl of the ligation product, ice-bath for 30 minutes, then heat shock at 42°C for 2 minutes, and then ice-bath for 2 minutes, then add 400 μl of LB liquid medium, shake and culture at 37°C for 1 hour at 150 rpm, and then apply An LB solid plate containing ampicillin (kan + ) was placed, and cultured upside down at 37°C for 16 hours.
(4)通过菌落PCR检测含重组质粒的菌株,筛选出阳性菌落 (4) Detect strains containing recombinant plasmids by colony PCR, and screen out positive colonies
① 观察转化平板,随机挑选几个菌落,用10μl枪头挑起,溶解在20μl ddH2O中,混匀后,转移10μl菌液到LB液体培养基中,剩余10μl菌液用于热裂解,裂解温度98℃,时间10min; ① Observe the transformation plate, pick several colonies at random, pick up with a 10μl pipette tip, dissolve in 20μl ddH 2 O, mix well, transfer 10μl of the bacterial solution to the LB liquid medium, and use the remaining 10μl of the bacterial solution for thermal lysis. Cracking temperature 98°C, time 10min;
② 裂解后用掌上离心机轻甩,裂解液用作菌落PCR模板; ② After lysing, use a handheld centrifuge to shake gently, and the lysate is used as a template for colony PCR;
③ 菌落PCR扩增反应体系如下: ③ Colony PCR amplification reaction system is as follows:
表4:反应体系组分 Table 4: Reaction System Components
④菌落PCR反应条件 ④ Colony PCR reaction conditions
将反应体系混匀后,在95℃预变性4min;然后在95℃变性45 s,60℃退火45 s,72℃延伸90 s,30个循环;72℃延伸10min;反应完成后取产物2 μl,在1%琼脂糖凝胶中进行电泳分析; After mixing the reaction system, pre-denature at 95°C for 4 minutes; then denature at 95°C for 45 s, anneal at 60°C for 45 s, and extend at 72°C for 90 s, 30 cycles; extend at 72°C for 10 min; take 2 μl of the product after the reaction is completed , carried out electrophoresis analysis in 1% agarose gel;
⑤ 鉴定出阳性菌落,并送至昆明硕阳生物科技公司进行测序。 ⑤ Positive colonies were identified and sent to Kunming Shuoyang Biotechnology Company for sequencing.
(5)阳性克隆增菌 (5) Positive clone enrichment
①取卡纳霉素5μl(终浓度100μg/ml)加入5ml LB培养基中; ① Add 5 μl of kanamycin (final concentration 100 μg/ml) into 5 ml of LB medium;
②用接种环挑取阳性克隆,接种于Kan+-LB培养基中; ②Pick positive clones with an inoculation loop and inoculate them in Kan + -LB medium;
③然后放入37℃摇床180rmp培养6-8h。 ③ Then put it into a shaker at 37°C at 180rmp and incubate for 6-8h.
重组质粒抽提 (采用质粒抽提试剂盒中提供的方法) Recombinant plasmid extraction (using the method provided in the plasmid extraction kit)
①收集菌体:把步骤(5)中培养的菌液加入到5ml的离心管中,离心收集菌体沉淀,弃上清液; ①Collect bacteria: Add the bacteria cultured in step (5) into a 5ml centrifuge tube, collect the bacteria precipitate by centrifugation, and discard the supernatant;
②加溶液Ⅰ(含RNA酶)250μl,振荡至菌体彻底分散均匀,转入1.5ml的EP管中; ② Add 250 μl of solution I (containing RNase), shake until the cells are thoroughly dispersed, and transfer to a 1.5ml EP tube;
③加入溶液Ⅱ 250μl,轻轻混匀,使溶液Ⅰ的RNA酶消化细菌中RNA; ③ Add 250 μl of solution II and mix gently to make the RNase in solution I digest the RNA in the bacteria;
加入溶液Ⅲ 350μl,温和混匀,12000rpm离心10min; Add 350 μl of solution III, mix gently, and centrifuge at 12000 rpm for 10 min;
⑤将上清液转入DNA吸附柱中,室温放置2min,混匀,12000rpm离心1 min,弃收集管中废液; ⑤ Transfer the supernatant to a DNA adsorption column, place at room temperature for 2 min, mix well, centrifuge at 12,000 rpm for 1 min, and discard the waste liquid in the collection tube;
⑥加入700 μl漂洗液于吸附柱中,12000rpm离心1min,弃废液(重复一次); ⑥ Add 700 μl rinse solution to the adsorption column, centrifuge at 12000rpm for 1min, discard the waste solution (repeat once);
⑦室温13000rpm,2min再离心一次,吸附柱敞口放置数分钟,以去除残存的漂洗液; ⑦ room temperature 13000rpm, centrifuge again for 2 minutes, and leave the adsorption column open for several minutes to remove the remaining rinse solution;
⑧将吸附柱移入新的1.5ml的离心管中,在吸附膜中央加入70μl 在65℃预热的洗脱液,室温放置1min,然后12000rpm室温离心2min,再重复一次以提高回收率; ⑧ Move the adsorption column into a new 1.5ml centrifuge tube, add 70 μl of eluent preheated at 65°C to the center of the adsorption membrane, place it at room temperature for 1 min, then centrifuge at 12000 rpm for 2 min at room temperature, and repeat it again to increase the recovery rate;
⑨将所得到的质粒取1 μl电泳分析。 ⑨ Take 1 μl of the obtained plasmid for electrophoresis analysis.
(6)重组质粒的酶切鉴定 (6) Enzyme digestion identification of recombinant plasmids
①酶切体系如下: ①The enzyme digestion system is as follows:
表5:反应体系组分 Table 5: Reaction System Components
②酶切条件:37℃,3h,取2μl跑琼脂糖凝胶电泳。 ②Enzyme digestion conditions: 37°C, 3h, take 2μl and run agarose gel electrophoresis.
(7)重组质粒pET28a-TSPcpn47转化表达菌株Rosetta(DE3) (7) The recombinant plasmid pET28a- TSPcpn47 was transformed into the expression strain Rosetta (DE3)
在100μl感受态细胞Rosetta(DE3)里,加入重组质粒3μl,冰浴30min,然后42℃热击1~2min,再冰浴2min,之后加入400μl LB液体培养基,于37℃,150rpm摇床培养1h,然后涂布含有氨苄青霉素(Kan+)的LB固体平板,于37℃倒置培养12h。 In 100 μl of competent cells Rosetta (DE3), add 3 μl of recombinant plasmid, ice-bath for 30 minutes, then heat shock at 42°C for 1-2 minutes, then ice-bath for 2 minutes, then add 400 μl of LB liquid medium, culture at 37°C, 150rpm shaker After 1 hour, LB solid plates containing ampicillin (Kan + ) were coated, and cultured upside down at 37° C. for 12 hours.
(8)分子伴侣TSPcpn47的诱导表达和纯化 (8) Induced expression and purification of molecular chaperone TSPcpn47
①TSP4噬菌体分子伴侣TSPcpn47在Rosetta(DE3)中的诱导表达 ① Induced expression of TSP4 phage chaperone TSPcpn47 in Rosetta (DE3)
将构建好的重组载体pET28a-TSPcpn47转化至表达宿主菌Rosetta(DE3)中,含重组质粒的菌株经37℃培养过夜,菌液按1%比例接种到100ml Kan+-LB(氨苄青霉素终浓度100μg/ml)培养液中,放入37℃摇床培养至其OD600为0.6;取出1ml菌液用作对照实验;其余菌液加入100mM IPTG储液至终浓度1mM,90 rpm摇床培养诱导表达8小时。 The constructed recombinant vector pET28a- TSPcpn47 was transformed into the expression host strain Rosetta (DE3), the strain containing the recombinant plasmid was cultured overnight at 37°C, and the bacterial solution was inoculated into 100ml Kan+-LB (final concentration of ampicillin 100μg/ ml) in the culture solution, cultured on a shaker at 37°C until its OD 600 was 0.6; 1ml of the bacterial solution was taken out as a control experiment; the rest of the bacterial solution was added to 100mM IPTG stock solution to a final concentration of 1mM, and cultured on a shaker at 90 rpm to induce the expression of 8 Hour.
TSP4cpn47蛋白进行SDS-PAGE检测 SDS-PAGE detection of TSP4cpn47 protein
取出少量诱导后菌液测OD值,根据菌液OD值不同取不同的菌液量,使其菌体量相等,12000rpm,离心5min,弃上清;加入80 μl ddH2O,20 μl 5×上样缓冲液,振荡使菌体散开后;在98℃下热裂解10min,使菌体释放蛋白质;将样品上样于电泳仪中在100V,60mA,电泳2h后,加入100ml R250考马斯亮蓝染色液染色,摇床振荡,100 rpm,20min后;将染色液倒出,用清水漂洗,再加入适量脱色液100 rpm,10h,最后用扫描仪扫描凝胶,检测蛋白表达情况(见图4),结果得到大小为29kD左右的目的蛋白条带,TSPcpn47在上清和沉淀中均有表达。 Take out a small amount of induced bacterial liquid to measure the OD value, take different amount of bacterial liquid according to the different OD value of the bacterial liquid to make the amount of bacterial cells equal, centrifuge at 12000rpm for 5min, discard the supernatant; add 80 μl ddH 2 O, 20 μl 5× Loading buffer solution, shaking to disperse the bacteria; thermally lyse at 98°C for 10 minutes to release the protein from the bacteria; load the sample on the electrophoresis instrument at 100V, 60mA, electrophoresis for 2 hours, add 100ml R250 Coomassie brilliant blue Stain with the staining solution, shake on a shaker, 100 rpm, after 20 minutes; pour out the staining solution, rinse with water, then add an appropriate amount of destaining solution at 100 rpm, for 10 hours, and finally scan the gel with a scanner to detect protein expression (see Figure 4 ), the result was a target protein band with a size of about 29kD, and TSPcpn47 was expressed in both the supernatant and the precipitate.
②重组解旋酶蛋白的纯化 ②Purification of recombinant helicase protein
利用上述方法大量诱导含重组质粒pET28a-TSPcpn47的Rosetta菌株,菌液经离心收集菌体(4℃,5000g,10 min),菌体悬浮于适量(使菌悬液的OD600达到20)缓冲液A[20 mM磷酸钠,500 mM NaCl ,30 mM 咪唑,pH 7.8] 中,冰上超声破碎细胞,4℃,10000 g离心15 min,上清上样于已用缓冲液A平衡好的His Trap HP柱(1 ml, GE Healthcare)中,结合的蛋白用20 ml 含有咪唑梯度(0-500 mM)的缓冲液B[20 mM 磷酸钠, 500 mM NaCl , 30 mM 咪唑,pH 7.4]洗脱,分段收集洗脱液,经SDS-PAGE检测后,最后用缓冲液[50 mM Tris-HCl,2 mM Mg2+,pH7.4] 透析过夜,获得重组蛋白TSPcpn47,纯化的重组蛋白组分进行SDS-PAGE分析(见图5)。 Use the above method to induce a large number of Rosetta strains containing the recombinant plasmid pET28a- TSPcpn47 , collect the bacteria by centrifugation (4°C, 5000g, 10 min), and suspend the bacteria in an appropriate amount of buffer (to make the OD 600 of the bacteria suspension reach 20) A [20 mM sodium phosphate, 500 mM NaCl, 30 mM imidazole, pH 7.8], sonicate the cells on ice, centrifuge at 10,000 g for 15 min at 4°C, and load the supernatant on the His Trap equilibrated with buffer A In the HP column (1 ml, GE Healthcare), the bound protein was eluted with 20 ml of buffer B [20 mM sodium phosphate, 500 mM NaCl, 30 mM imidazole, pH 7.4] containing imidazole gradient (0-500 mM), The eluate was collected in sections, detected by SDS-PAGE, and finally dialyzed overnight with buffer [50 mM Tris-HCl, 2 mM Mg2+, pH7.4] to obtain recombinant protein TSPcpn47, and the purified recombinant protein fraction was subjected to SDS- PAGE analysis (see Figure 5).
(9)重组分子伴侣TSPcpn47可溶性表达条件摸索 (9) Explore the soluble expression conditions of the recombinant molecular chaperone TSPcpn47
表达菌pET28a-TSPcpn47/Rosetta于28℃培养条件下,1mM IPTG诱导目的蛋白的表达,以转入不含目的片段的pET-28a质粒的pET28a /Rosetta作为对照,离心收集菌体,超声破碎细胞,再次离心后分别收集上清和沉淀,利用SDS-PAGE检测分别检测上清和沉淀中重组蛋白的表达情况(见图5)。 The expression strain pET28a- TSPcpn47 /Rosetta was cultured at 28°C, and the expression of the target protein was induced by 1mM IPTG. The pET28a/Rosetta transformed into the pET-28a plasmid without the target fragment was used as a control, and the bacteria were collected by centrifugation, and the cells were sonicated. After centrifuging again, the supernatant and the precipitate were collected respectively, and the expression of the recombinant protein in the supernatant and the precipitate was detected by SDS-PAGE (see Figure 5).
(10)重组蛋白TSPcpn47含量的测定 (10) Determination of recombinant protein TSPcpn47 content
蛋白含量测定采用Bradford法检测,试剂:考马斯亮蓝G-250储存液、1mg/mL的BSA标准蛋白溶液;缓冲液:pH8.0,50mmol/L的Tris-HCl缓冲液。 Protein content was determined by Bradford method, reagents: Coomassie Brilliant Blue G-250 stock solution, 1 mg/mL BSA standard protein solution; buffer: pH 8.0, 50 mmol/L Tris-HCl buffer.
步骤为:取7个1.5ml effendorf管分别加入BSA、待测样品液、去离子水、考马斯亮蓝G-250储存液,混匀在5~20 min内,用紫外分光光度计测其波长为595 nm处的吸光度值,以浓度为0 mg/mL的BSA溶液作为空白对照,具体方法如下表所示。 The steps are: take seven 1.5ml effendorf tubes and add BSA, sample solution to be tested, deionized water, and Coomassie Brilliant Blue G-250 stock solution respectively, mix well within 5-20 min, and measure the wavelength with a UV spectrophotometer. For the absorbance value at 595 nm, the BSA solution with a concentration of 0 mg/mL was used as a blank control, and the specific method is shown in the table below. the
表6:各组分及使用量 Table 6: Components and dosage
根据不同浓度标准蛋白测定结果绘制标准曲线,以蛋白浓度为横坐标,以OD值为纵坐标绘制标准曲线(见图6),根据未知蛋白的OD值,可在标准曲线上查出该蛋白的浓度。 Draw a standard curve according to the determination results of standard proteins with different concentrations. Take the protein concentration as the abscissa and the OD value as the ordinate to draw the standard curve (see Figure 6). According to the OD value of the unknown protein, the protein can be detected on the standard curve. concentration.
计算公式: Calculation formula:
待测样品蛋白浓度(mg/ml)=测定样品的OD值/标准蛋白的OD值×标准蛋白的浓度×稀释倍数 Protein concentration of the sample to be tested (mg/ml) = OD value of the test sample/OD value of the standard protein × concentration of the standard protein × dilution factor
利用此方法测定蛋白纯化液中重组蛋白TSPcpn47含量:测得OD595为0.093,代入蛋白标准曲线方程得到蛋白浓度为0.0697μg/μL。 Use this method to determine the content of recombinant protein TSPcpn47 in the protein purification solution: the measured OD595 is 0.093, and the protein concentration is 0.0697 μg/μL when substituted into the protein standard curve equation.
(11)分子伴侣TSPcpn47的ATPase活性的检测 (11) Detection of ATPase activity of molecular chaperone TSPcpn47
利用BioAssay Systems公司的ATPase检测试剂盒检测分子伴侣TSPcpn47的ATPase活性。 The ATPase activity of the molecular chaperone TSPcpn47 was detected using the ATPase detection kit from BioAssay Systems.
①磷酸盐浓度标准曲线制作 ① Preparation of phosphate concentration standard curve
制备800μl 磷酸盐浓度为50μM的磷酸盐预混合液(40μl 1mM磷酸盐标准液与760μl的ddH2O混合),准备一干净96孔板,按照下列表格进行加样,通过试剂盒检测获得磷酸盐浓度标准曲线如图7所示。 Prepare 800μl phosphate premix solution with a phosphate concentration of 50μM (mix 40μl 1mM phosphate standard solution with 760μl ddH2O), prepare a clean 96-well plate, add samples according to the following table, and obtain the phosphate concentration standard through the detection of the kit The curve is shown in Figure 7.
②ATPase活性的检测 ② Detection of ATPase activity
设定40uL反应量,酶样品,灭活的酶和Tris-HCl缓冲液对照分别放入不同的孔中 Set the reaction volume to 40uL, put the enzyme sample, inactivated enzyme and Tris-HCl buffer control into different wells respectively
制备三份平行的样品,分别置于37℃,45℃,55℃条件下反应30min,然后加入200μL显色剂终止反应,室温静置30min,在波长630nm处,读取OD值。 Prepare three parallel samples and place them at 37°C, 45°C, and 55°C for 30 minutes, then add 200 μL of chromogen to terminate the reaction, let stand at room temperature for 30 minutes, and read the OD value at a wavelength of 630 nm.
酶活定义:一单位酶活相当于在检测条件下,每分钟每毫克蛋白催化产生1μmol磷酸盐离子的量,定义为1U。 根据酶活定义计算其ATPase酶活力为1.36U。 Definition of enzyme activity: One unit of enzyme activity is equivalent to the amount of 1 μmol phosphate ion catalyzed per milligram of protein per minute under the detection conditions, defined as 1U. According to the definition of enzyme activity, its ATPase enzyme activity is 1.36U. the
③温度对分子伴侣TSPcpn47的影响 ③The effect of temperature on molecular chaperone TSPcpn47
同样,利用ATPase活性测定试剂盒提供的试剂和方法,以10℃为一个梯度,测定不同温度对重组蛋白分子伴侣TScpn47的ATPase活力的影响(见图8),结果表明,其在40——70℃具有ATPase活性,以60℃为最适酶活温度。 Similarly, using the reagents and methods provided by the ATPase activity assay kit, with a gradient of 10°C, the effects of different temperatures on the ATPase activity of the recombinant protein chaperone TScpn47 were measured (see Figure 8). °C has ATPase activity, and 60 °C is the optimum temperature for enzyme activity.
(12)分子伴侣TSPcpn47帮助GFP恢复荧光实验(见图9) (12) Molecular chaperone TSPcpn47 helps GFP restore fluorescence experiments (see Figure 9)
①取状态良好的U2OS细胞加入6孔细胞培养板,转染前4h更换未加双抗和血清的DMEM高糖培养基(美国Gibco原装); ① Take U2OS cells in good condition and add them to a 6-well cell culture plate, and replace with DMEM high-glucose medium (original Gibco, USA) without double antibody and serum 4 hours before transfection;
②制备转染液 ② Preparation of transfection solution
pEGFP质粒5μg溶于200μl DMEM中; Dissolve 5 μg of pEGFP plasmid in 200 μl DMEM;
Lipofect转染剂10μl溶于200μl DMEM中; Dissolve 10 μl of Lipofect transfection reagent in 200 μl DMEM;
③pEGFP质粒溶液分别与lipofect溶液混合后于室温静置20min再均匀加入细胞培养液中,37℃,5%CO2培养12h; ③The pEGFP plasmid solution was mixed with the lipofect solution respectively, and then allowed to stand at room temperature for 20 minutes, then evenly added to the cell culture medium, and cultured at 37°C, 5% CO 2 for 12 hours;
④24h后,弃去旧培养液,用1×PBS清洗细胞表面2次,加适量的0.25%胰酶,晃动细胞培养瓶,使胰酶均匀覆盖细胞,37℃静置消化,至细胞单层变得模糊,出现小的裂纹,轻轻拍打至细胞全部脱落为止; ④After 24 hours, discard the old culture medium, wash the cell surface twice with 1×PBS, add an appropriate amount of 0.25% trypsin, shake the cell culture flask to make the trypsin evenly cover the cells, and let it stand for digestion at 37°C until the monolayer of cells changes. If it becomes blurred and small cracks appear, gently pat until all the cells fall off;
⑤收集1mL细胞悬液(胰蛋白处理),于4℃,1000rpm离心2min,弃上清,沉淀用1mL的100 mM Tris-HC1(pH7.8)的缓冲液重悬,然后进行超声破碎3min(15%功率,破碎5s,暂停3s),破碎结束以后至于冰上备用; ⑤Collect 1mL of cell suspension (trypsin treatment), centrifuge at 4°C, 1000rpm for 2min, discard the supernatant, resuspend the pellet with 1mL of 100 mM Tris-HC1 (pH7.8) buffer, and then ultrasonicate for 3min ( 15% power, crushing for 5s, pause for 3s), after the crushing is over, put it on ice for standby;
⑥向绿色荧光蛋白GFP(10mM)中加入HCl至终浓度0.1mM,室温下(约25℃)变性1 h; ⑥ Add HCl to the green fluorescent protein GFP (10mM) to a final concentration of 0.1mM, and denature at room temperature (about 25°C) for 1 h;
⑦用缓冲液(100 mM Tris-HC1,40mmol/L MgC12,pH7.8)稀释100倍复性,同时加入分子伴侣TSPcpn47(终浓度0.2μg/μL)和ATP(终浓度4.0 mM),以加入等物质的量浓度的牛血清白蛋白(BSA)后GFP的复性情况,及GFP自身的稀释复性情况作为对照; ⑦ Dilute 100-fold refolding with buffer (100 mM Tris-HC1, 40 mmol/L MgC12, pH7.8), and add molecular chaperone TSPcpn47 (final concentration 0.2 μg/μL) and ATP (final concentration 4.0 mM) to add The renaturation situation of GFP after bovine serum albumin (BSA) of equal substance concentration, and the dilution renaturation situation of GFP itself are used as controls;
⑧用荧光酶标仪Fluostar Optima,以480nm激发,520nm发射,实时测定荧光变化,以0.1 mol/L Native GFP荧光强度为100%,结果见图9,TSPcpn47能显著提高酸变性后的绿色荧光蛋白复性效果,具备协助恢复其功能的能力。 ⑧Using a fluorescent microplate reader Fluostar Optima, excitation at 480nm, emission at 520nm, real-time measurement of fluorescence changes, with 0.1 mol/L Native GFP fluorescence intensity as 100%, the results are shown in Figure 9, TSPcpn47 can significantly increase the green fluorescent protein after acid denaturation Refolding effect, has the ability to assist in restoring its function. the
(13)分子伴侣TSPcpn47对 GFP热稳定性的影响 (13) Effect of molecular chaperone TSPcpn47 on the thermal stability of GFP
①将分子伴侣TSPcpn47与GFP蛋白以1:1的摩尔比进行混合,然后加入ATP至终浓度4mmol/L; ①Mix the molecular chaperone TSPcpn47 and GFP protein at a molar ratio of 1:1, and then add ATP to a final concentration of 4mmol/L;
②60℃保温60 min,每10 min取一次样,测定残存荧光强度,以0 min时的酶活力为100%; ②Incubate at 60°C for 60 min, take a sample every 10 min, measure the residual fluorescence intensity, and take the enzyme activity at 0 min as 100%;
③以加入等摩尔比的小牛血清蛋白(BSA)后GFP在60℃时的热稳定性,以及GFP蛋白在60℃的热稳定性变化,即荧光强度变化作为对照,结果见图10,TSPcpn47能显著提高绿色荧光蛋白热稳定能力,具备协助功能蛋白在高温环境下维持其生理活性。 ③ Take the thermal stability of GFP at 60°C after adding bovine serum albumin (BSA) in an equimolar ratio, and the thermal stability change of GFP protein at 60°C, that is, the change of fluorescence intensity as a control. The results are shown in Figure 10, TSPcpn47 It can significantly improve the thermal stability of green fluorescent protein, and assist the functional protein to maintain its physiological activity in a high temperature environment.
序列表 sequence listing
<110> 昆明理工大学 <110> Kunming University of Science and Technology
<120> 一种分子伴侣TSPcpn47和编码此分子伴侣的多核苷酸 <120> A molecular chaperone TSPcpn47 and a polynucleotide encoding the molecular chaperone
<160> 4 <160> 4
<170> PatentIn version 3.5 <170> PatentIn version 3.5
the
<210> 1 <210> 1
<211> 204 <211> 204
<212> PRT <212> PRT
<213> 噬菌体TSP4 <213> Phage TSP4
the
<400> 1 Met Asp Ile Gly Gly Leu Met Asp Pro Leu Ala Ile Glu Gly Thr <400> 1
1 5 10 15 1 5 10 15
Val Ile Leu Gln Asp Gly Gln Thr Ile Leu Lys Pro Ser Pro Phe Val Ile Leu Gln Asp Gly Gln Thr Ile Leu Lys Pro Ser Pro Phe
16 20 25 30 16 20 25 30
Leu Gln Ala Leu Leu Thr Ala Lys Glu Gly Lys Arg Val Gly Leu Leu Gln Ala Leu Leu Thr Ala Lys Glu Gly Lys Arg Val Gly Leu
31 35 40 45 31 35 40 45
Val Leu Asp Glu Ile Asn Arg Gly His Pro Thr Ala Leu Asn Arg Val Leu Asp Glu Ile Asn Arg Gly His Pro Thr Ala Leu Asn Arg
46 50 55 60 46 50 55 60
Val Phe Arg Leu Leu Ala Gln Arg Gln Phe His Ser Asp Trp Tyr Val Phe Arg Leu Leu Ala Gln Arg Gln Phe His Ser Asp Trp Tyr
61 65 70 75 61 65 70 75
Gly Leu Leu Asp Leu Lys Gly Lys Asp Leu Val Val Ile Ser Thr Gly Leu Leu Asp Leu Lys Gly Lys Asp Leu Val Val Ile Ser Thr
76 80 85 90 76 80 85 90
Ala Asn Ala Gly Val Glu Tyr Thr Val Ser Lys Leu Asp Arg Ala Ala Asn Ala Gly Val Glu Tyr Thr Val Ser Lys Leu Asp Arg Ala
91 95 100 105 91 95 100 105
Met Arg Glu Arg His Leu Trp Ile Tyr Val Pro Arg Pro Asp Pro Met Arg Glu Arg His Leu Trp Ile Tyr Val Pro Arg Pro Asp Pro
106 110 115 120 106 110 115 120
Ser Val Val Phe Thr Val Leu Gln Glu Arg Val Pro Asn Leu Thr Ser Val Val Phe Thr Val Leu Gln Glu Arg Val Pro Asn Leu Thr
121 125 130 135 121 125 130 135
Pro Ala Gln Ala Glu Val Ile Thr Asn Leu Tyr Ala Ala Ser Asp Pro Ala Gln Ala Glu Val Ile Thr Asn Leu Tyr Ala Ala Ser Asp
136 140 145 150 136 140 145 150
Gln Leu Leu Gly Val Arg Glu Ser Leu Asp Ile Ala Tyr Leu Leu Gln Leu Leu Gly Val Arg Glu Ser Leu Asp Ile Ala Tyr Leu Leu
151 155 160 165 151 155 160 165
Ala Asn Gly Val Asp Leu Gln Ser Ala Val Glu Leu Thr Val Lys Ala Asn Gly Val Asp Leu Gln Ser Ala Val Glu Leu Thr Val Lys
166 170 175 180 166 170 175 180
Gly Ala Ala Tyr Val Ser Asn Thr Ala Leu Glu Val Ala Asp Gly Gly Ala Ala Tyr Val Ser Asn Thr Ala Leu Glu Val Ala Asp Gly
181 185 190 195 181 185 190 195
Leu Ile Ala Ser Ala Lys Ala Leu Thr Leu Ile Ala Ser Ala Lys Ala Leu Thr
196 200 204 196 200 204
the
<210> 2 <210> 2
<211> 612 <211> 612
<212> DNA <212> DNA
<213> TSP4噬菌体 <213> TSP4 phage
the
<400> 2 <400> 2
atggacattg gtggtctcat ggacccgcta gctattgaag gtacggtcat 50 atggacattg gtggtctcat ggacccgcta gctattgaag gtacggtcat 50
cttgcaggac gggcagacca tccttaagcc ctctcccttc ctgcaagctc 100 cttgcaggac gggcagacca tccttaagcc ctctcccttc ctgcaagctc 100
ttttgacggc caaggaggga aaacgggtgg gtttggtgct ggatgagatt 150 ttttgacggc caaggaggga aaacgggtgg gtttggtgct ggatgagatt 150
aatcgcgggc atcccaccgc cctcaaccgt gtgttcaggc ttctggccca 200 aatcgcgggc atcccaccgc cctcaaccgt gtgttcaggc ttctggccca 200
gaggcagttc cactccgact ggtacgggtt gcttgacctc aagggcaagg 250 gaggcagttc cactccgact ggtacgggtt gcttgacctc aagggcaagg 250
acctggtggt catttccacg gccaatgcgg gcgtagagta tacggttagt 300 acctggtggt catttccacg gccaatgcgg gcgtagagta tacggttagt 300
aagcttgacc gggccatgcg tgagcggcac ctgtggatat atgttcccag 350 aagcttgacc gggccatgcg tgagcggcac ctgtggatat atgttcccag 350
gcctgacccg tctgtagtgt ttaccgttct gcaggaacgg gtgccgaatt 400 gcctgacccg tctgtagtgt ttaccgttct gcaggaacgg gtgccgaatt 400
tgacgcctgc acaagcagag gttattacca atctttacgc agcttcggat 450 tgacgcctgc acaagcagag gttattacca atctttacgc agcttcggat 450
cagcttctag gcgtgcgcga atctttggat atcgcctact tgctggctaa 500 cagcttctag gcgtgcgcga atctttggat atcgcctact tgctggctaa 500
tggtgtggac ctgcagtctg ctgtggaact cacggtcaag ggggcggctt 550 tggtgtggac ctgcagtctg ctgtggaact cacggtcaag ggggcggctt 550
atgtcagcaa cacagccttg gaggtggcag acgggcttat tgctagcgct 600 atgtcagcaa cacagccttg gaggtggcag acgggcttat tgctagcgct 600
aaggctctga cc 612 aaggctctga cc 612
the
<210> 3 <210> 3
<211> 26 <211> 26
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
the
<400> 3 <400> 3
cggaattcat ggcactctta tctaac 26 cggaattcat ggcactctta tctaac 26
the
<210> 4 <210> 4
<211> 27 <211> 27
<212> DNA <212> DNA
<213> 人工序列 <213> Artificial sequence
the
<400> 4 <400> 4
acatctcgag ccatgaggcc acctcct 27 acatctcgag ccatgaggcc acctcct 27
Claims (2)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310364132.8A CN103435689B (en) | 2013-08-20 | 2013-08-20 | Molecular chaperone TSPcpn47 and polynucleotide encoding same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310364132.8A CN103435689B (en) | 2013-08-20 | 2013-08-20 | Molecular chaperone TSPcpn47 and polynucleotide encoding same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103435689A CN103435689A (en) | 2013-12-11 |
| CN103435689B true CN103435689B (en) | 2015-03-11 |
Family
ID=49689424
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310364132.8A Expired - Fee Related CN103435689B (en) | 2013-08-20 | 2013-08-20 | Molecular chaperone TSPcpn47 and polynucleotide encoding same |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103435689B (en) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1418954A (en) * | 2001-11-12 | 2003-05-21 | 杭州华大基因研发中心 | High temp. resistant HSP 70 molecular chaperone and coded polypeptide and preparation process thereof |
| US8013129B2 (en) * | 2003-12-19 | 2011-09-06 | Agency For Science, Technology And Research | Protein separation device |
-
2013
- 2013-08-20 CN CN201310364132.8A patent/CN103435689B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN103435689A (en) | 2013-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112004932B (en) | A kind of CRISPR/Cas effector protein and system | |
| JP5242388B2 (en) | Method for secretory expression of lysostaphin in E. coli at high levels | |
| CN113195521B (en) | Mtu delta I-CM intein variants and uses thereof | |
| CN106497897A (en) | A kind of engineered strain construction method for improving Heparinase I activity | |
| JP2009502125A5 (en) | ||
| CN107973857B (en) | Recombinant fusion protein based on bacterial surface display system and application thereof | |
| CN107779461B (en) | A genetic modification method for introducing polyamine tags, soluble expression of lipase and biomimetic immobilization method | |
| CN103436514A (en) | Heat-resistant lyase TSPpgh and polynucleotide coding same | |
| CN101570756B (en) | New-type label protein and application thereof | |
| CN114560915A (en) | Modified high-titer SARS-CoV-2 pseudovirus | |
| CN117440963A (en) | Recombinant protein purification method | |
| CN108285918A (en) | A kind of outer SUMOization modification quick detection kit of proteosome | |
| CN108285919A (en) | A kind of outer ubiquitination quick detection kit of proteosome | |
| CN101921800B (en) | Escherichia coli protein expression vector using trigger factor as fusion tag and construction method and application thereof | |
| CN111378047A (en) | Fusion tag protein for improving protein expression and application thereof | |
| CN103435689B (en) | Molecular chaperone TSPcpn47 and polynucleotide encoding same | |
| CN110511950B (en) | Application of PAB protein in construction of fusion protein expression vector with chaperone-like protein effect | |
| CN109777807B (en) | Method for positioning and expressing foreign protein in mitochondria | |
| CN107217064A (en) | Superoxide dismutase gene and its encoded protein | |
| CN110746496A (en) | A kind of PAL recombinant protein of Acinetobacter baumannii and its encoding gene and their application | |
| Ahlqvist et al. | Crystal structure and initial characterization of a novel archaeal-like Holliday junction-resolving enzyme from Thermus thermophilus phage Tth15-6 | |
| CN113755474B (en) | Carboxypeptidase, and coding gene and application thereof | |
| CN114163506B (en) | Application of Pseudomonas stutzeri-derived PsPIWI-RE protein in mediating homologous recombination | |
| CN104946606A (en) | Genetic engineering transformed thermal-resistant adverse-resistant SOD as well as encoding gene and application thereof | |
| Kant et al. | DNA binding and pairing activity of OsDmc1, a recombinase from rice |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20170713 Address after: 650093 Ring Road in Yunnan city of Kunming province No. 50 Kunming University of Science and Technology Xinying Campus Patentee after: INDUSTRY MANAGEMENT LTD KUNMING University OF SCIENCE AND TECHNOLOGY Address before: 650093 Kunming, Yunnan, Wuhua District Road, No. 253 Patentee before: Kunming University of Science and Technology |
|
| TR01 | Transfer of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150311 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |